CSIMarket
 


Mallinckrodt Plc  (MNKKQ)
Other Ticker:  
 
 

MNKKQ's Revenue Growth by Quarter and Year

Mallinckrodt Plc's Revenue results by quarter and year




MNKKQ Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter January - 597.20 682.80 804.90
III Quarter October - 507.20 698.30 743.70
II Quarter July - 546.40 166.50 823.30
I Quarter April 490.90 558.00 665.80 790.60
FY   490.90 2,208.80 2,213.40 3,162.50



MNKKQ Revenue first quarter 2022 Y/Y Growth Comment
Mallinckrodt Plc reported fall in Revenue in the first quarter 2022 by -12.03% to $ 490.90 millions, from the same quarter in 2021.
The decline in the first quarter 2022 Mallinckrodt Plc's Revenue compares unfavorably to the Company's average Revenue growth of 7.05%.

Looking into first quarter 2022 results within Major Pharmaceutical Preparations industry 192 other companies have achieved higher Revenue growth. While Mallinckrodt Plc' s Revenue decrease of -12.03% ranks overall at the positon no. 3336 in the first quarter 2022.




MNKKQ Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter January - -12.54 % -15.17 % -41.3 %
III Quarter October - -27.37 % -6.1 % 16.2 %
II Quarter July - 228.17 % -79.78 % 30.33 %
I Quarter April -12.03 % -16.19 % -15.79 % 38.07 %
FY   - -0.21 % -30.01 % -1.65 %

Financial Statements
Mallinckrodt Plc's first quarter 2022 Revenue $ 490.90 millions MNKKQ's Income Statement
Mallinckrodt Plc's first quarter 2021 Revenue $ 558.00 millions Quarterly MNKKQ's Income Statement
New: More MNKKQ's historic Revenue Growth >>


MNKKQ Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter January - 17.74 % -2.22 % 8.23 %
III Quarter October - -7.17 % 319.4 % -9.67 %
II Quarter July - -2.08 % -74.99 % 4.14 %
I Quarter April -17.8 % -18.28 % -17.28 % -42.35 %
FY (Year on Year)   - -0.21 % -30.01 % -1.65 %




Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #193
Healthcare Sector #497
Overall #3336

Revenue Y/Y Growth Statistics
High Average Low
228.17 % 7.05 % -79.78 %
(Jun 25 2021)   (Jun 26 2020)
Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #193
Healthcare Sector #497
Overall #3336
Revenue Y/Y Growth Statistics
High Average Low
228.17 % 7.05 % -79.78 %
(Jun 25 2021)   (Jun 26 2020)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Mallinckrodt Plc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
319.4 % 12.57 % -74.99 %
(Sep 25 2020)  


MNKKQ's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Mallinckrodt Plc realized fall in Revenue from the fourth quarter by -17.8% to $ 490.90 millions, from $ 597.20 millions achived in the previous reporting period.

But that's not huge issue, as Revenue frequently tend to slow in this quarter Aidan Hill, market veteran from Seattle wrote.

Within Major Pharmaceutical Preparations industry 188 other companies have achieved higher Revenue quarter on quarter growth. While Mallinckrodt Plc's Revenue growth quarter on quarter, overall rank is 3232.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #189
Healthcare Sector #487
Overall #3232
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #189
Healthcare Sector #487
Overall #3232
Revenue Q/Q Growth Statistics
High Average Low
319.4 % 12.57 % -74.99 %
(Sep 25 2020)  


MNKKQ's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Mallinckrodt Plc realized fall in Revenue sequentially by -17.8% to $ 490.90 millions, from $ 597.20 millions released a quarter before.

As we analyse recent downturn in the quarter, we suppose to presume, that frequently I. Quarter Revenue occur sluggish in contrast to the fourth quarter, Aidan Hill, market veteran from Seattle added.

Within Major Pharmaceutical Preparations industry 188 other companies have achieved higher Revenue quarter on quarter growth. While Mallinckrodt Plc's Revenue growth quarter on quarter, overall rank is 3232.


Mallinckrodt Plc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Apr 01 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 24 2021)
12 Months Ending
(Jun 25 2021)
12 Months Ending
(Mar 26 2021)
Cumulative Revenue 12 Months Ending $ 2,141.70 $ 2,208.80 $ 2,294.40 $ 2,485.50 $ 2,105.60
Y / Y Revenue Growth (TTM) 1.71 % -0.21 % -1.76 % 4.39 % -30.68 %
Year on Year Revenue Growth Overall Ranking # 721 # 2356 # 2052 # 2253 # 2851
Seqeuential Revenue Change (TTM) -3.04 % -3.73 % -7.69 % 18.04 % -4.87 %
Seq. Revenue Growth (TTM) Overall Ranking # 3160 # 2604 # 2530 # 607 # 3126




Cumulative Revenue growth Comment
Although Mallinckrodt Plc's Annual Revenue growth year on year were below company's average 1.96% , Revenue announced in the Apr 01 2022 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.71% year on year, from -0.21% in Dec 31 2021.

In the Healthcare sector 61 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 721, from total ranking in previous quarter at 2356.

Revenue TTM Q/Q Growth Statistics
High Average Low
120.71 %
1.96 %
-37.37 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 146
Healthcare Sector # 62
Overall # 721

Revenue TTM Y/Y Growth Statistics
High Average Low
120.71 %
1.96 %
-37.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 146
Sector # 426
S&P 500 # 3160
Cumulative Revenue growth Comment
Although Mallinckrodt Plc's Annual Revenue growth year on year were below company's average 1.96% , Revenue announced in the Apr 01 2022 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 1.71% year on year, from -0.21% in Dec 31 2021.

In the Healthcare sector 61 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 721, from total ranking in previous quarter at 2356.

Revenue TTM Q/Q Growth Statistics
High Average Low
120.71 %
1.96 %
-37.37 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 146
Healthcare Sector # 62
Overall # 721

Revenue TTM Y/Y Growth Statistics
High Average Low
120.71 %
1.96 %
-37.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 146
Sector # 426
S&P 500 # 3160




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MNKKQ's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for MNKKQ's Competitors
Revenue Growth for Mallinckrodt Plc's Suppliers
Revenue Growth for MNKKQ's Customers

You may also want to know
MNKKQ's Annual Growth Rates MNKKQ's Profitability Ratios MNKKQ's Asset Turnover Ratio MNKKQ's Dividend Growth
MNKKQ's Roe MNKKQ's Valuation Ratios MNKKQ's Financial Strength Ratios MNKKQ's Dividend Payout Ratio
MNKKQ's Roa MNKKQ's Inventory Turnover Ratio MNKKQ's Growth Rates MNKKQ's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Apr 01 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Apr 01 2022
Medtronic Plc-1.21%$ -1.209 millions
National Vision Holdings Inc -1.21%$ -1.211 millions
Ortho Clinical Diagnostics Holdings Plc-1.32%$ -1.322 millions
Revvity Inc -3.69%$ -3.689 millions
Envista Holdings Corporation-10.97%$ -10.970 millions
Lakeland Industries Inc -19.99%$ -19.987 millions
Enzo Biochem Inc-20.05%$ -20.048 millions
Advaxis Inc -81.82%$ -81.818 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com